Baosheng Science and Technology Innovation Co.,Ltd. (SHA:600973)
China · Delayed Price · Currency is CNY 7.44
+0.02 (0.27%)
May 7, 2026, 3:00 PM CST
SHA:600973 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 51,716 | 47,256 | 45,557 | 42,918 | 40,742 | 42,279 |
Other Revenue | 702.34 | 702.34 | 803.34 | 880.64 | 739.81 | 710.44 |
| 52,418 | 47,959 | 46,360 | 43,798 | 41,482 | 42,989 | |
Revenue Growth (YoY) | 8.38% | 3.45% | 5.85% | 5.58% | -3.51% | 25.39% |
Cost of Revenue | 50,351 | 45,942 | 44,328 | 41,483 | 39,362 | 40,229 |
Gross Profit | 2,067 | 2,017 | 2,032 | 2,315 | 2,119 | 2,760 |
Selling, General & Admin | 770.06 | 760.24 | 905.91 | 877.71 | 829.62 | 900.18 |
Research & Development | 612.89 | 576.48 | 700.23 | 748.07 | 705.21 | 727.87 |
Other Operating Expenses | 58.88 | 75.25 | 20.67 | 41.96 | 90.4 | 69.65 |
Operating Expenses | 1,546 | 1,516 | 2,063 | 1,787 | 1,655 | 1,907 |
Operating Income | 521.21 | 500.76 | -31.23 | 528.35 | 464.77 | 853.6 |
Interest Expense | -364.32 | -364.32 | -465.35 | -475.01 | -520.88 | -544.08 |
Interest & Investment Income | 26.29 | 26.29 | 189.09 | 74.61 | 69.13 | 64.06 |
Currency Exchange Gain (Loss) | -1.35 | -1.35 | -0.3 | -16.96 | 57.06 | -2.92 |
Other Non Operating Income (Expenses) | -34.74 | -36.57 | -39.32 | -35.74 | -24.65 | -26.06 |
EBT Excluding Unusual Items | 147.1 | 124.81 | -347.11 | 75.25 | 45.44 | 344.61 |
Impairment of Goodwill | -8.27 | -8.27 | -17.9 | -11.33 | -14.32 | - |
Gain (Loss) on Sale of Investments | -128.23 | -127.21 | 14.62 | -66.21 | - | - |
Gain (Loss) on Sale of Assets | 3.38 | 4.08 | -6.53 | -2.8 | 0.51 | 0.7 |
Asset Writedown | -0.06 | - | -43.8 | -1.5 | - | - |
Legal Settlements | 0.17 | 0.17 | 4.37 | 3.14 | 12.22 | - |
Other Unusual Items | 30.64 | 30.64 | 37.11 | 58.51 | 50 | -1,050 |
Pretax Income | 44.73 | 24.22 | -359.23 | 55.07 | 93.85 | -705.06 |
Income Tax Expense | 48.39 | 40.12 | -36.86 | 9.49 | 28.88 | -59.68 |
Earnings From Continuing Operations | -3.66 | -15.9 | -322.37 | 45.58 | 64.97 | -645.38 |
Minority Interest in Earnings | -13.22 | -27.99 | 22.51 | -14.56 | 0.37 | -117.38 |
Net Income | -16.88 | -43.89 | -299.86 | 31.02 | 65.34 | -762.76 |
Net Income to Common | -16.88 | -43.89 | -299.86 | 31.02 | 65.34 | -762.76 |
Net Income Growth | - | - | - | -52.52% | - | - |
Shares Outstanding (Basic) | 1,475 | 1,463 | 1,363 | 1,551 | 1,307 | 1,362 |
Shares Outstanding (Diluted) | 1,475 | 1,463 | 1,363 | 1,551 | 1,307 | 1,362 |
Shares Change (YoY) | 8.92% | 7.33% | -12.13% | 18.71% | -4.06% | 1.94% |
EPS (Basic) | -0.01 | -0.03 | -0.22 | 0.02 | 0.05 | -0.56 |
EPS (Diluted) | -0.01 | -0.03 | -0.22 | 0.02 | 0.05 | -0.56 |
EPS Growth | - | - | - | -60.00% | - | - |
Free Cash Flow | 648.46 | 572.42 | -1,156 | 695.76 | -57.01 | -217.52 |
Free Cash Flow Per Share | 0.44 | 0.39 | -0.85 | 0.45 | -0.04 | -0.16 |
Dividend Per Share | - | - | - | - | - | 0.048 |
Gross Margin | 3.94% | 4.21% | 4.38% | 5.29% | 5.11% | 6.42% |
Operating Margin | 0.99% | 1.04% | -0.07% | 1.21% | 1.12% | 1.99% |
Profit Margin | -0.03% | -0.09% | -0.65% | 0.07% | 0.16% | -1.77% |
Free Cash Flow Margin | 1.24% | 1.19% | -2.49% | 1.59% | -0.14% | -0.51% |
EBITDA | 871.07 | 897.46 | 552.88 | 1,072 | 969.01 | 1,310 |
EBITDA Margin | 1.66% | 1.87% | 1.19% | 2.45% | 2.34% | 3.05% |
D&A For EBITDA | 349.85 | 396.7 | 584.1 | 543.8 | 504.24 | 456.66 |
EBIT | 521.21 | 500.76 | -31.23 | 528.35 | 464.77 | 853.6 |
EBIT Margin | 0.99% | 1.04% | -0.07% | 1.21% | 1.12% | 1.99% |
Effective Tax Rate | 108.19% | 165.63% | - | 17.23% | 30.77% | - |
Revenue as Reported | 47,959 | 47,959 | 46,360 | 43,798 | 41,482 | 42,989 |
Advertising Expenses | - | 2.2 | 2.08 | 3.1 | 2.25 | 3.4 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.